Related references
Note: Only part of the references are listed.Approach to the Treatment of Patients with Serious Multidrug-ResistantPseudomonas aeruginosaInfections
J. Nicholas O Donnell et al.
PHARMACOTHERAPY (2020)
Geographic and Temporal Patterns of Antimicrobial Resistance in Pseudomonas aeruginosa Over 20 Years From the SENTRY Antimicrobial Surveillance Program, 1997-2016
Dee Shortridge et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Activity of imipenem-relebactam against multidrug-resistant Pseudomonas aeruginosa from the United States - SMART 2015-2017
James A. Karlowsky et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2019)
Outcomes of empiric aminoglycoside monotherapy for Pseudomonas aeruginosa bacteremia
Kady Phe et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2019)
Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review
Preeti Pachori et al.
GENES & DISEASES (2019)
Antibiotic resistance rates for Pseudomonas aeruginosa clinical respiratory and bloodstream isolates among the Veterans Affairs Healthcare System from 2009 to 2013
Haley J. Appaneal et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)
Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: A Multicenter Study
Jason C. Gallagher et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Andrew Rhodes et al.
INTENSIVE CARE MEDICINE (2017)
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Andre C. Kalil et al.
CLINICAL INFECTIOUS DISEASES (2016)
An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance
Scott T. Micek et al.
CRITICAL CARE (2015)
Epidemiology and Predictors of Multidrug-Resistant Community-Acquired and Health Care-Associated Pneumonia
Alan E. Gross et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Antimicrobial co-resistance patterns of gram-negative bacilli isolated from bloodstream infections: a longitudinal epidemiological study from 2002-2011
Patrick H. P. Wong et al.
BMC INFECTIOUS DISEASES (2014)
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Pranita D. Tamma et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes
Elizabeth B. Hirsch et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2010)
Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
Philip D. Lister et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections:: Impact of delayed appropriate antibiotic selection
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials
Liat Vidal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Length of stay - An appropriate quality measure?
Karen J. Brasel et al.
ARCHIVES OF SURGERY (2007)
Fluoroquinolone-resistant Pseudomonas aeruginosa:: Assessment of risk factors and clinical impact
Leanne B. Gasink et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact
V Aloush et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections
B Cao et al.
JOURNAL OF HOSPITAL INFECTION (2004)
Share Paper
